In cancer with dyspnea, high-dose dexamethasone did not improve dyspnea and increased SAEs

Michael Certo; Robert Arnold

doi:10.7326/J22-0106

In cancer with dyspnea, high-dose dexamethasone did not improve dyspnea and increased SAEs

Ann Intern Med. 2023 Jan;176(1):JC7. doi: 10.7326/J22-0106. Epub 2023 Jan 3.

Authors

Michael Certo¹, Robert Arnold¹

Affiliation

¹ University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA (M.C., R.A.).

PMID: 36592463
DOI: 10.7326/J22-0106

Abstract

Hui D, Puac V, Shelal Z, et al. Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial. Lancet Oncol. 2022;23:1321-31. 36087590.

Publication types

Randomized Controlled Trial
Comment

MeSH terms

Dexamethasone / therapeutic use
Double-Blind Method
Dyspnea / drug therapy
Dyspnea / etiology
Humans
Neoplasms* / complications

Substances

Dexamethasone